Last week we talked about Stem cell research getting the “green light” and this week we continue with our stem cell blog series. Biology has long...

One welcome result of the pharmaceutical innovation crisis is a shift from blockbuster drugs to rare disease drugs. We are doing our own part to...

One of Scientist’s most popular blog posts of last year was an infographic depicting American attitudes towards stem cell research. Part of that...

Pharmaceutical innovation is a broad term that can encompass and affect any step of the drug discovery and development process, so how exactly are...

Scientific research in circadian rhythm has determined that our genes can quite accurately predict the time of our death due to natural causes...

With the fiscal cliff negotiations over for now, we turn our attention to the patent cliff. A lot of industry watchers and participants often...

Scientist’s Kevin Lustig recently blogged on mendelspod, explaining how the cost of drug development for pharmaceutical companies often leads to...

Since the National Human Genome Research Institute (NHGRI) initiated a program in 2004 to advance sequencing technology development, the resulting...

We all know bacon and other fatty foods can lead to obesity, diabetes, and cardiovascular diseases but the four-legged creature from where these...

Next generation sequencing has reduced costs and increased the throughput, as compared to Sanger sequencing. Importantly, it has expanded the...